Wednesday, May 21 2025
9:40–10:25am
Industry Theater
Opportunities to Reduce the Rising Tide of Cardiovascular Events Through Better LDL-C Management
Industry Theater 1, South Meeting Rooms 164-166
Description
Cardiovascular disease is still the leading cause of death in the United States and the trend is moving in the wrong direction, with 2022 setting a record for deaths due to cardiovascular disease in the US at close to 1 million. LDL-cholesterol is a major modifiable cardiovascular risk factor which continues to be poorly controlled.
The Family Heart Foundation is a non-profit organization dedicated to research, education, and advocacy and as part of our ongoing research efforts, we have examined the state of LDL-C control among 38M Americans at high and very high-risk for cardiovascular disease in the proprietary Family Heart Database. This session will provide an update on current LDL-C treatment guidelines and focus on key findings and insights from an analysis of the Family Heart database.